> All trial participants previously completed the primary two-dose series of the Pfizer-BioNTech vaccine, and then were randomized 1:1 to receive either a 30-µg booster dose (the same dosage strength as those in the primary series) or placebo. The median time between second dose and administration of the booster dose or placebo was approximately 11 months. Symptomatic COVID-19 occurrence was measured from at least 7 days after booster or placebo, with a median follow-up of 2.5 months. During the study period, there were 5 cases of COVID-19 in the boosted group, and 109 cases in the non-boosted group. The observed relative vaccine efficacy of 95.6% (95% CI: 89.3, 98.6) reflects the reduction in disease occurrence in the boosted group versus the non-boosted group in those without evidence of prior SARS-CoV-2 infection. Median age of participants was 53 years, with 55.5% of participants between 16 and 55 years, and 23.3% of participants 65 years and older.
Sure, but with the new Delta Plus® variant (+ false-negative tests + asymptomatic transmission) it's better to play it safe & keep your distance from other human resources.
> The Leger survey, conducted for the Association of Canadian Studies, found that more than three in four respondents hold negative views of those who are not immunized.
> S.V. Subramanian, the Harvard professor of population health and geography behind the paper [Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States], says the vaccine doubters are completely wrong.
> “That conclusion is misleading and inaccurate,” Subramanian told me of Horowitz’s Blaze column over email. “This paper supports vaccination as an important strategy for reducing infection and transmission, along with hand-washing, mask-wearing, and physical distancing.”
> We note that almost 43% of patients after influenza had at least one long-COVID feature recorded (Table 1) including 29.7% during the 90- to 180-day period. In this regard, we suggest researchers take a broad and balanced view as to the nature and specificity of long-COVID.
Ryokan, a Zen master, lived the simplest kind of life in a little hut at the foot of a mountain. One evening a thief visited the hut only to discover there was nothing to steal.
Ryokan returned and caught him. "You have come a long way to visit me," he told the prowler, "and you should not return empty-handed. Please take my clothes as a gift."
The thief was bewildered. He took the clothes and slunk away.
Ryoken sat naked, watching the moon. "Poor fellow," he mused, "I wish I could have given him this beautiful moon."